阿里巴巴(09988.HK):獲螞蟻集團派息 錄股息收入39.45億人幣
據阿里巴巴(09988.HK)昨日業績披露,螞蟻集團向股東派息,阿里應收股息約39.45億人民幣。
《證券日報》報道,對於分紅方案,螞蟻集團方面回應稱,本次利潤分配方案著眼於公司長期可持續發展和股東合理回報,綜合考慮了公司財務狀況、經營發展規劃等因素,感謝股東長期以來對公司的支持。
螞蟻集團方面同時透露,公司主要股東杭州君瀚和杭州君澳的自然人股東自願承諾,收到的相應分紅將留存在杭州君瀚和杭州君澳層面,用以增強其財務實力和對公司的資本補充能力,以配合公司的整改推進、促進公司長期可持續發展。資料顯示,杭州君瀚和杭州君澳的自然人股東主要由螞蟻創始團隊和管理層構成。(wl/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.